1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Page confirms May 25 deadline for new applications, renewals, and resubmissions, matching the stored deadline of 2026-05-25.
NIMH Mentoring Networks for Mental Health Research Education is sponsored by National Institute of Mental Health (NIMH). This NOFO supports innovative educational activities with a primary focus on national or regional mentoring networks that enhance professional development and foster career trajectories towards independent mental health research.
These networks should provide significant new opportunities beyond existing mentoring programs.
Get alerted about grants like this
Save a search for “National Institute of Mental Health (NIMH)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NIMH Mentoring Networks for Mental Health Research Education (R25) - National Institute of Mental Health (NIMH) Due to current HHS and NIH restructuring, some content on nimh. nih. gov is not being updated regularly.
Please refer to clinicaltrials. gov and nih. gov for up-to-date information on NIH research.
Opportunities & Announcements Funding Strategy for Grants Grant Writing & Approval Process NIMH Mentoring Networks for Mental Health Research Education (R25) This award supports research education activities that advance the NIMH mission with a primary focus on mentoring activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs.
Notice of funding opportunity PAR-23-263, R25: NIMH Mentoring Networks for Mental Health Research Education - Clinical Trial Not Allowed New applications, renewals, and resubmissions: May 25 Program director(s)/principal investigator(s) (PD(s)/PI(s)) eligibility The PD(s)/PI(s) should be an established investigator in the scientific area in which the application is targeted and capable of providing both administrative and scientific leadership to the development and implementation of the proposed program.
The PD(s)/PI(s) should have a strong track record as a leader, educator, and/or mentor in an area relevant to the scientific focus of the proposed mentoring network and should be actively engaged in research educator in a scientific area related to the mission of the NIMH. Mentors should have research expertise and experience relevant to the proposed program.
Mentors must be committed to continue their involvement throughout the total period of the mentee’s participation in this award and for a period of no less than one year. Unless strongly justified on the basis of exceptional relevance to NIH, research education programs should be used primarily for the education of U.S. citizens and permanent residents.
Participants are limited to graduate/medical students, medical residents, postdoctoral scholars, and/or early-career investigators.
U.S. domestic institutions Foreign components allowed While the proposed research education program may complement ongoing research training and education occurring at the applicant institution, the proposed educational experiences must be distinct from those research training and research education programs currently receiving federal support.
It is expected that a combination of didactic interactions (e.g., in the form of week-long summer institutes and/or regularly occurring webinars), one-on-one, and small group discussions will be components of any proposed mentoring network. Both formal and informal interactions between mentors and participants are expected.
Applicants are encouraged to take advantage of contemporary communication strategies, e.g., distance learning and social networking, as appropriate for the goals of their network.
For Renewal Applications, the description of the proposed network for the next funding period should highlight how the program continues to offer research education at the scientific cutting-edge as well as any changes in activities that are planned to maintain the currency of the research education offered.
Renewal applications should describe the continuing need for the existing network to advance NIMH's goal of a well-trained pool of researchers with state-of-the-art knowledge and skills essential for achieving the Institute's research priorities. For complete guidance on the components of the Research Education Program Plan, see Section IV of the funding opportunity .
Application budgets may not exceed $200,000 in direct costs annually and are expected to reflect actual needs of the proposed project. The scope of the proposed project should determine the project period. The maximum period is 5 years.
Indirect Costs (also known as Facilities & Administrative [F&A] Costs) are reimbursed at 8% of modified total direct costs (exclusive of tuition and fees, expenditures for equipment and consortium costs in excess of $25,000), rather than on the basis of a negotiated rate agreement.
Individuals designing, directing, and implementing the research education program may request salary and fringe benefits appropriate for the person months devoted to the program. Salaries requested may not exceed the levels commensurate with the institution's policy for similar positions and may not exceed the congressionally mandated cap.
If mentoring interactions and other activities with participants are considered a regular part of an individual's academic duties, then any costs associated with the mentoring and other interactions with participants are not allowable costs from grant funds.
Administrative and clerical costs, as well as salaries of the PD/PI associated with directing, coordinating, administering, and implementing the program should be well-justified, reasonable, and may not exceed 25% of the total direct costs in any year. Consultant costs may not be used to substitute for these costs.
Participants may be compensated for participation in activities specifically required by the proposed research education program, if sufficiently justified. Participant costs must be itemized in the proposed budget. Other program-related costs Consultant costs, equipment, supplies, travel for key persons, and other program-related expenses may be included in the proposed budget.
These expenses must be justified as specifically required by the proposed program and must not duplicate items generally available at the applicant institution. Consultant costs may not be used to substitute for Personnel costs.
Potential applicants are strongly encouraged to review the funding opportunity and the FAQs below prior to contacting the appropriate NIMH Research Training and Career Development representative for additional information. Have additional questions?
Career Development Programs (K-Series) NIH Research Training and Career Development FAQs NIMH Guidance for Responsible Conduct of Research (RCR) Training Requirements Q: Is a letter of intent required as part of the R25 application?
A: No. Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows institute staff to estimate the potential review workload and plan the review. Q: How will my R25 application be evaluated? Q: I would like to participate as a mentor, but I work at a foreign institution.
Am I eligible to participate in this R25 program? A: Yes. Programs that include faculty participation through a foreign component should be well-justified and should clearly describe the benefit to the research education program (e.g., unique expertise of the faculty member).
Q: I am currently supported by another NIH research training and career development award. Am I eligible to supplement my stipend with this R25 program? A: No. R25 funds cannot be used to provide additional salary or stipend support to individuals supported by NIH training and career development mechanisms, such as K-, T-, or F-series awards).
The R25 program is not intended as a substitute for an NRSA institutional training program (e.g., T32), costs to support full-time participants (supported for 40 hours/week for a continuous, 12-month period) are not allowable. However, PIs on other training awards may receive, and indeed are encouraged to receive, educational experiences supported by an R25 program.
Based on current listing details, eligibility includes: Investigators with expertise and insights in mentoring networks within research education activities. PhD students would benefit as mentees within these networks. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Up to $200,000 Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is September 12, 2025. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) is sponsored by National Institute of Mental Health (NIMH), National Institutes of Health (NIH). This funding opportunity is a companion to the R21 mechanism and also aims to stimulate research to understand the link between social disconnection and suicidal thoughts and behaviors in late life. It focuses on identifying mechanisms by which social disconnection confers risk for, and social integration protects against, suicidal thoughts and behaviors in late life. This R01 mechanism is appropriate for applications with preliminary data.
Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional) is sponsored by National Institute of Mental Health (NIMH) / NIH. This funding opportunity encourages research focused on optimizing and testing school-based mental and behavioral health interventions and service delivery models. It seeks applications that will study methods to increase access to evidence-based interventions and services for youth mental health, particularly in under-resourced areas. Research areas include optimizing assessment, intervention and service strategies, overcoming workforce shortages, and integrating preventive interventions into settings like schools.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.